filmov
tv
Coronavirus: Moderna CEO on the promising preliminary results of early-stage study
Показать описание
Moderna’s closely watched early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all 45 participants, the biotech company announced Monday. Moderna CEO Stephane Bancel joins "Squawk Box" to discuss.
For more coronavirus live updates:
For access to live and exclusive video from CNBC subscribe to CNBC PRO:
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
#CNBC
#CNBC TV
For more coronavirus live updates:
For access to live and exclusive video from CNBC subscribe to CNBC PRO:
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
#CNBC
#CNBC TV
Moderna CEO on Covid-19 vaccine timeline, how it might be distributed and more
Coronavirus: Moderna CEO on the promising preliminary results of early-stage study
Moderna CEO Stephane Bancel on the Race for a Covid-19 Vaccine
Moderna CEO defends $130 COVID vaccine price
Coronavirus: Moderna CEO on timeline for phase one vaccine results
COVID-19: Moderna CEO hopeful for COVID and flu combo vaccine in the future
Coronavirus vaccine: Moderna CEO discusses vaccine rollout, variant booster shots, and production
Moderna CEO Says Covid-19 Vaccine a ‘Game Changer’
Coronavirus vaccine: Moderna CEO breaks down emergency use authorization, distribution, and efficacy
Coronavirus vaccine: Moderna CEO discusses vaccine development
Moderna CEO Says Covid Vaccine Could Face Distribution Delays In Europe | NBC News NOW
Moderna CEO Hopes Covid Booster Shot Ready by Fall
Moderna CEO: Most exciting vaccine data is protection from severe Covid-19
Coronavirus vaccine: Moderna CEO talks vaccine pricing, human testing begins and COVID-19 cases rise
Moderna CEO on raising Covid vaccine manufacturing goals
COVID-19 ‘is not leaving the planet,’ Moderna CEO says
Coronavirus vaccine: Moderna CEO discusses 94.5 efficacy rate and distribution
Moderna CEO Hopeful Americans Can Get Booster Shot Next Week
Coronavirus vaccine: Moderna CEO talks phase 3 of vaccine development, human trials and efficacy
Moderna CEO: We hope to have Covid booster shot ready by the fall
Moderna CEO on its 94.5% effective Covid-19 vaccine: We hope to get it to market soon
Moderna CEO Bancel: Future Covid vaccine booster will likely target omicron variant
Coronavirus Is Not Too Complicated, Says Moderna CEO
Moderna CEO answers questions on COVID vaccine efficacy
Комментарии